Oriol Mirallas, Clinical Fellow in the Investigational Cancer Therapeutics (ICT) Department at the The University of Texas MD Anderson Cancer Center, shared a post on X:
“ESMO2025 Berlin is SOON here.
My Top10 for NSCLC
Many important trials and potentially practice-changing
Follow the global dream team.”
More posts featuring ESMO25.